Back to Search
NANCY BROWN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1265499750Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
P00001112(TN)
Clinical Trials (7)
7
Linked Trials
0
Recruiting
5
With Results
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
NCT04649229ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
NCT04113109COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of DPP4 Inhibition on Vasoconstriction
NCT02639637COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.
NCT02129725COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
NCT00872599COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
NCT00775671COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
NCT00666848COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
PMID 30415601·N Engl J Med·2019
4-observational
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
PMID 27170530·Eur J Heart Fail·2016
4-observational
Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
PMID 25173047·Prostaglandins Other Lipid Mediat·2014
8-other
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
PMID 25176015·N Engl J Med·2014
4-observational
Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.
PMID 23385647·J Hypertens·2013
2-rct
Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.
PMID 22353614·Hypertension·2012
2-rct
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
PMID 20679179·Hypertension·2010
2-rct
Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.
PMID 19581505·Hypertension·2009
8-other
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
PMID 16432054·Hypertension·2006
2-rct
ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
PMID 12468570·Hypertension·2002
3-trial
The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease.
PMID 12224047·Semin Nephrol·2002
6-review
Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen.
PMID 11397722·Arterioscler Thromb Vasc Biol·2001
8-other
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
PMID 11056091·Circulation·2000
3-trial
The sexual relationships of sexual-minority women partnered with trans men: a qualitative study.
PMID 19609665·Arch Sex Behav·2010
8-other
Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis.
PMID 19628666·J Am Soc Nephrol·2009
2-rct
Automated stimulus-response mapping of high-electrode-count neural implants.
PMID 19666339·IEEE Trans Neural Syst Rehabil Eng·2009
7-preclinical
Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase.
PMID 19672877·Protein Sci·2009
8-other
Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.
PMID 19623180·Br J Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 301 S GALLAHER VIEW RD, SUITE 102
KNOXVILLE, TN 37919 - Phone
- (865) 690-0962
Quick Facts
- NPI
- 1265499750
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile